Comment on Umpierrez and Klonoff. Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital. Diabetes Care 2018;41:1579–1589
- Jennifer Grammes1,2⇑,
- Eva Kuestner2,
- Lutz Heinemann2,3 and
- Thomas Kubiak1,2
- 1Health Psychology, Johannes Gutenberg University, Mainz, Germany
- 2Diabetes Technology Working Group, German Diabetes Association, Ulm, Germany
- 3Science-Consulting in Diabetes GmbH, Neuss, Germany
- Corresponding author: Jennifer Grammes, jegramme{at}uni-mainz.de
We applaud Umpierrez and Klonoff (1) for reviewing the evidence on the application of insulin pump therapy (continuous subcutaneous glucose infusion [CSII]) and continuous glucose monitoring in inpatient settings. However, we missed a dedicated section about the patients’ perspective and experiences concerning insulin pump use in hospitals. In a qualitative survey conducted in Germany, elderly patients with type 1 diabetes (≥65 years, n = 136) and health care professionals (HCP, n = 96) were asked about their wishes, concerns, and needs related to CSII (2). The 290 responses (165 patients; 125 HCPs) were classified into three categories.
First were positive experiences (patients n = 17; HCPs n = 5), which were a result of perceived respect of the …
In this Issue
